Abstract
A new radioimmunoassay for secretin was used to investigate (a) serum secretin responses to intraduodenally infused HCl and glucose, (b) the metabolic half-life and the volume of distribution of exogenous secretin and (c) the effect of endogenously released secretin on insulin secretion in 25 anesthetized dogs. Portal and femoral venous blood samples were taken simultaneously before, during, and after intraduodenal infusion of HCl (21 meq/30 min) and glucose (131 ml/30 min). Control experiments were performed with intraduodenal infusion of saline. Mean portal venous immunoreactive secretin concentration of six dogs rose from 313 muU/ml before to 1,060 muU/ml 10 min after initiation of the intestinal acidification (P < 0.005). Femoral venous immunoreactive secretin concentration rose from 220 muU/ml before to 567 muU/ml 15 min after intestinal acidification (P < 0.01). Secretin concentrations remained elevated during the remainder of the infusion. In the same six dogs mean portal venous immunoreactive insulin concentration rose from 38 muU/ml before to 62 muU/ml at the end of the infusion (P < 0.05). Peripheral immunoreactive insulin, glucose, and free fatty acid concentrations, however, did not change significantly. Pancreatic exocrine function was studied in four dogs. The rise in secretin concentration was followed promptly by a highly significant increase in exocrine pancreatic flow rate and bicarbonate secretion, indicating biological activity of the circulating immunoreactive secretin. The effect of intraduodenal infusion of glucose on immunoreactive secretin concentration was studied in 12 dogs. Glucose in concentrations ranging from 2.5% to 10% had no detectable influence on portal or peripheral secretin concentration. Infusion of 50% glucose caused a slight decline in secretin concentration. The metabolic clearance rate, half-life of disappearance, and volume of distribution of exogenous secretin was studied in three dogs by the constant infusion technic. The metabolic clearance rate was 730+/-34 ml/min, volume of distribution was 17.4+/-0.8% of body weight, and the half-life of disappearance was 2.8+/-0.1 min. It could be calculated that 1.38 U/kg-h(-1) of endogenous secretin was released into the peripheral circulation during the steady state period of the HCl infusion experiments. The data indicated that immunoreactive secretin was released rapidly after intestinal acidification, continued to be secreted throughout the duration of HCl infusion, and was promptly distributed in the extracellular compartment. Furthermore, they suggested that endogenously released secretin could stimulate insulin secretion. The HCl-mediated insulinogenic effect of immunoreactive secretin, however, was too weak to influence peripheral immunoreactive insulin, glucose, and free fatty acid concentrations. The failure of intraduodenal glucose to stimulate secretin release suggests that secretin is not the insulin-stimulatory factor released from the gastrointestinal tract in response to glucose.
MeSH Terms
Animals
Bicarbonates/metabolism
Blood Glucose/metabolism
Dogs
Duodenum
Fatty Acids, Nonesterified/blood
Femoral Vein
Glucose/administration & dosage,pharmacology
Half-Life
Hydrochloric Acid/administration & dosage,pharmacology
Insulin/blood
Metabolic Clearance Rate
Pancreas/drug effects,metabolism
Portal Vein
Secretin/blood
Time Factors
Chemicals
Bicarbonates
Blood Glucose
Fatty Acids, Nonesterified
Insulin
Secretin
Glucose
Hydrochloric Acid
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Boden G
Essa N
Owen O E
Reichle F A
References (32)
32 references, click to expand
-
The gastrointestinal stimulus to insulin release. II. A dual action of secretin.
J Clin Invest. 1970 Mar;49(3):524-9
PMID: 5415678
-
Failure of endogenous stimulation of secretin and pancreozymin release to influence serum-insulin.
Lancet. 1968 Mar 2;1(7540):448-51
PMID: 4169787
-
[Direct stimulation of insulin secretion in vitro by scretion].
Dtsch Med Wochenschr. 1965 Sep 17;90(38):1663-9
PMID: 5318184
-
An automated determination of glucose utilizing a glucose oxidase-peroxidase system.
J Lab Clin Med. 1961 Jun;57:970-80
PMID: 13714284
-
Anatomy of body water and electrolytes.
Am J Med. 1959 Aug;27:256-77
PMID: 13819266
-
Secretory rate of gastric acid and pancreatic bicarbonate in the dog after feeding.
Gastroenterology. 1967 Jun;52(6):930-9
PMID: 6026487
-
Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA).
Endocrinology. 1973 Jun;92(6):1617-24
PMID: 4350502
-
Radioimmunoassay of secretin in human serum.
J Nucl Med. 1968 Dec;9(12):641-2
PMID: 5729213
-
Steroid dynamics under steady-state conditions.
Recent Prog Horm Res. 1969;25:611-64
PMID: 4900738
-
[Determination of the half life time of secretin].
Klin Wochenschr. 1969 Nov 15;47(22):1200-4
PMID: 5376916
-
Effect of secretin on insulin secretion.
Lancet. 1966 Jul 2;2(7453):24-6
PMID: 4161053
-
The gastrointestinal stimulus to insulin release. I. Secretin.
J Clin Invest. 1969 Aug;48(8):1453-60
PMID: 5796357
-
Pancreatic response to acidification of various lengths of proximal intestine in the dog.
Am J Physiol. 1970 Oct;219(4):971-7
PMID: 5459499
-
Portal vein blood flow determination in the unanesthetized human by umbilicoportal cannulation.
J Surg Res. 1972 Mar;12(3):146-50
PMID: 4336462
-
The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.
J Clin Invest. 1967 Apr;46(4):630-45
PMID: 4290022
-
Intestinal hormones and plasma insulin: an insulinotropic action of secretin.
Br Med J. 1967 Jun 10;2(5553):676-8
PMID: 6024527
-
Comparison of secretin response to oral intraduodenal or intravenous glucose administration.
Horm Metab Res. 1971 May;3(3):180-3
PMID: 5123994
-
The duodenal secretion in man as a function of secretin dose and secretin inactivation.
Gastroenterology. 1962 Aug;43:174-80
PMID: 14461535
-
Critical variables in the radioimmunoassay of serum insulin using the double antibody technic.
Diabetes. 1965 Dec;14(12):771-9
PMID: 5850216
-
The colorimetric micro-determination of long-chain fatty acids.
Biochem J. 1963 Jul;88(1):7-10
PMID: 16749030
-
Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man.
J Clin Invest. 1971 Aug;50(8):1702-11
PMID: 5097575
-
Effect of intraduodenal instillation of hydrochloric acid on plasma insulin levels of patients with portocaval shunts.
Metabolism. 1970 Mar;19(3):214-8
PMID: 4906365
-
Response to duodenal acidification in man. 3. Comparison with the effects of secretin and pancreozymin.
Scand J Gastroenterol. 1970;5(5):353-60
PMID: 5455820
-
A relation between non-esterified fatty acids in plasma and the metabolism of glucose.
J Clin Invest. 1956 Feb;35(2):150-4
PMID: 13286333
-
Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion.
Diabetes. 1970 May;19(5):302-6
PMID: 5443433
-
Heterogeneity of parathyroid hormone. Clinical and physiologic implications.
J Clin Invest. 1973 Aug;52(8):1958-71
PMID: 4719672
-
Intestinal hormones and plasma-insulin.
Lancet. 1966 Feb 19;1(7434):409-10
PMID: 4159788
-
Physiological determination of release of secretin and pancreozymin from intestine of dogs with transplanted pancreas.
Am J Physiol. 1951 Feb;164(2):527-45
PMID: 14810962
-
[Blood sugar and plasma insulin response to stimulation of endogenous secretin release].
Diabetologia. 1969 Aug;5(4):228-32
PMID: 4902719
-
Immunological comparison of natural and synthetic secretins.
Horm Metab Res. 1973 Jul;5(4):237-40
PMID: 4738489
-
Quantitative aspects of response of canine pancreas to duodenal acidification.
Am J Physiol. 1966 Mar;210(3):629-34
PMID: 5933217
-
The mechanism of pancreatic secretion.
J Physiol. 1902 Sep 12;28(5):325-53
PMID: 16992627